{
  "actions": [
    {
      "acted_at": "2018-05-22", 
      "action_code": "10000", 
      "references": [], 
      "text": "Introduced in Senate", 
      "type": "action"
    }, 
    {
      "acted_at": "2018-05-22", 
      "action_code": "", 
      "committees": [
        "SSFI"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Finance.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s2909-115", 
  "bill_type": "s", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "Senate Finance", 
      "committee_id": "SSFI"
    }
  ], 
  "congress": "115", 
  "cosponsors": [
    {
      "bioguide_id": "B001267", 
      "district": null, 
      "name": "Bennet, Michael F.", 
      "original_cosponsor": true, 
      "sponsored_at": "2018-05-22", 
      "state": "CO", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "M001183", 
      "district": null, 
      "name": "Manchin, Joe, III", 
      "original_cosponsor": false, 
      "sponsored_at": "2018-09-12", 
      "state": "WV", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2018-05-22", 
  "number": "2909", 
  "official_title": "A bill to require the Comptroller General of the United States to study and report on State Medicaid agencies' options related to the distribution of substance use disorder treatment medications under the Medicaid program.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "s3120-115", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }, 
    {
      "bill_id": "hr6-115", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }
  ], 
  "short_title": "Assessing Barriers to Opioid Use Disorder Treatment Act", 
  "sponsor": {
    "bioguide_id": "H001041", 
    "district": null, 
    "name": "Heller, Dean", 
    "state": "NV", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2018-05-22", 
  "subjects": [
    "Congressional oversight", 
    "Drug therapy", 
    "Drug trafficking and controlled substances", 
    "Drug, alcohol, tobacco use", 
    "Government studies and investigations", 
    "Health", 
    "Medicaid", 
    "Prescription drugs"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced in Senate", 
    "date": "2018-05-22T04:00:00Z", 
    "text": "Assessing Barriers to Opioid Use Disorder Treatment Act\n\nThis bill requires the Government Accountability Office to report on barriers to the provision of medication used to treat substance use disorders (e.g., buprenorphine) under Medicaid distribution models (e.g., provider purchasing, storage, and administration of medications)."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "A bill to require the Comptroller General of the United States to study and report on State Medicaid agencies' options related to the distribution of substance use disorder treatment medications under the Medicaid program.", 
      "type": "official"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Assessing Barriers to Opioid Use Disorder Treatment Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Assessing Barriers to Opioid Use Disorder Treatment Act", 
      "type": "short"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Assessing Barriers to Opioid Use Disorder Treatment Act", 
      "type": "display"
    }
  ], 
  "updated_at": "2019-04-18T16:43:24Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/115/s/BILLSTATUS-115s2909.xml"
}